Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4425 AUD | -0.56% | +14.94% | +28.26% |
03:03am | Canaccord Starts Immutep at Buy, Price Target is AU$1.00 | MT |
04-24 | Immutep Shows Positive Data in Trial to Treat Squamous Cell Cancers in Head, Neck | MT |
Evolution of the average Target Price on Immutep Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Immutep Limited
Baird | |
Maxim | |
Ladenburg Thalmann |
EPS Revisions
- Stock Market
- Equities
- IMM Stock
- Consensus Immutep Limited